ACADIA Pharmaceuticals Inc (ACAD)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 732,793 | 577,180 | 516,700 | 464,044 | 431,755 | 362,174 | 395,793 | 374,258 | 400,413 | 425,686 | 434,848 | 444,797 | 540,894 | 566,955 | 564,838 | 581,606 | 627,009 | 654,867 | 663,013 | 638,382 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $732,793K)
= 0.00
The debt-to-capital ratio for ACADIA Pharmaceuticals Inc has consistently been at 0.00 over the reported periods from March 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 signifies that the company has no debt in its capital structure. This indicates that the company is not utilizing debt financing to fund its operations, investments, or growth opportunities. A lower debt-to-capital ratio typically indicates lower financial risk and a more conservative financial structure. In the case of ACADIA Pharmaceuticals Inc, the stable and low debt-to-capital ratio reflects a strong financial position with a lower reliance on debt to support its business activities.
Peer comparison
Dec 31, 2024